DUBLIN--(BUSINESS WIRE)--The "Cell-based Assays: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.
This report reviews global markets and new developments for cell-based assays and forecasts trends for the use of these assays for drug discovery, safety and toxicology through 2023.
The report includes details of important assays, technologies and the latest developments and outlines market shares by assay type and company, with a special emphasis on the U.S. market. Statistical information on the prevalence of types of cancers worldwide is also included.
The report also details current issues and trends affecting the industry, as well as costs and factors that have an impact on demand. It covers products in development, new technologies, trends, and alliances and mergers. The report offers market data by segment and region and discusses market trends with respect to drivers, restraints and opportunities.
Companies Profiled
- ACEA Biosciences
- BD Biosciences
- Beckman Coulter
- Caliper Life Sciences
- Cellular Dynamics International
- Celsis In Vitro Technologies (Celsis Ivt)
- Cisbio Bioassays
- Discoverx Corp.
- EMD Millipore
- Endonovo Therapeutics
- Enzo Life Sciences
- Evotec Ag
- GE Healthcare
- Hemogenix
- Life Technologies
- Lonza
- Molecular Devices (Danaher)
- Oncolmmunin
- Origene Technologies
- Perkinelmer
- Promega Corp.
- Roche Group
- Stemcells Inc.
- Thermo Fisher Scientific
- TTP Labtech
- Vitro Biopharma
- Vivo Biosciences
Key Topics Covered
Chapter 3 Overview
Chapter 4 Assays for Drug Discovery
Chapter 5 Cell-based Assays - Current Technologies
Chapter 6 Commercialization of Cell-based Assays
Chapter 7 Global Cell-based Assay and Instrumentation Market
Chapter 8 Global Markets
Chapter 9 Company Profiles
